title: Toxicity and immunogenicity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes.
abstract: To obtain nontoxic and highly immunogenic lipopolysaccharide (LPS) for immunization, we incorporated Neisseria meningitidis LPS into liposomes. Native LPS and its salts were incorporated by the method of dehydration-rehydration of vesicles or prolonged cosonication. The most complete incorporation of LPS into liposomes and a decrease in toxicity were achieved by the method of dehydration-rehydration of vesicles. Three forms of LPS (H+ form, Mg2+ salt, and triethanolamine salt) showed different solubilities in water, the acidic form of LPS, with the most pronounced hydrophobic properties, being capable of practically complete association with liposomal membranes. An evaluation of the activity of liposomal LPS in vitro (by the Limulus amoebocyte test) and in vivo (by monitoring the pyrogenic reaction in rabbits) revealed a decrease in endotoxin activity of up to 1,000-fold. In addition, the pyrogenic activity of liposomal LPS was comparable to that of a meningococcal polysaccharide vaccine. Liposomes had a pronounced adjuvant effect on the immune response to LPS. Thus, the level of anti-LPS plaque-forming cells in the spleens of mice immunized with liposomal LPS was 1 order of magnitude higher and could be observed for a longer time (until day 21, i.e., the term of observation) than in mice immunized with free LPS. The same regularity was revealed in a study done with an enzyme-linked immunosorbent assay. This study also established that antibodies induced by immunization belonged to the immunoglobulin M and G classes, which are capable of prolonged circulation. Moreover, liposomal LPS induced a pronounced immune response in CBA/N mice (defective in B lymphocytes of the LyB-5+ subpopulation). The latter results indicate that the immunogenic action of liposomal LPS occurs at an early age.
authors.affiliation: Mechnikov Research Institute for Vaccines & Sera, Moscow, Russia.
authors.forename: A B
authors.initials: AB
authors.lastname: Petrov
authors.forename: B F
authors.initials: BF
authors.lastname: Semenov
authors.forename: Y P
authors.initials: YP
authors.lastname: Vartanyan
authors.forename: M M
authors.initials: MM
authors.lastname: Zakirov
authors.forename: V P
authors.initials: VP
authors.lastname: Torchilin
authors.forename: V S
authors.initials: VS
authors.lastname: Trubetskoy
authors.forename: N V
authors.initials: NV
authors.lastname: Koshkina
authors.forename: V L
authors.initials: VL
authors.lastname: L'Vov
authors.forename: I K
authors.initials: IK
authors.lastname: Verner
authors.forename: I V
authors.initials: IV
authors.lastname: Lopyrev
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D005334:Fever / Q000139:chemically induced; D008033:Limulus Test; D008070:Lipopolysaccharides / Q000008:administration & dosage* / Q000276:immunology / Q000633:toxicity; D008081:Liposomes / Q000008:administration & dosage; D051379:Mice; D008808:Mice, Inbred CBA; D009345:Neisseria meningitidis / Q000472:pathogenicity*; D011817:Rabbits; D010948:Viral Plaque Assay
chemical_list: D000907:Antibodies, Bacterial; D008070:Lipopolysaccharides; D008081:Liposomes